Boston Scientific (NYSE:BSX) today announced that a study of its Acurate neo2 aortic valve system missed its primary endpoint ...

Nonetheless, Boston Scientific claimed a healthy third quarter, with the firm delivering better than expected on both the top ...

Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in ...

The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...

Key Takeaways Boston Scientific shares fell Wednesday as its third-quarter profit missed estimates.The medical device maker's ...

Boston Scientific’s long-awaited transcatheter aortic heart valve missed its mark in a head-to-head study aimed at bringing the implant to the U.S.—but the company believ | Boston Scientific’s ...

Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Wells Fargo & Company from $87.00 to $98.00 in ...

Boston Scientific (NYSE:BSX – Free Report) had its target price hoisted by Sanford C. Bernstein from $92.00 to $100.00 in a ...

Boston Scientific Corp., one of the largest medical device firms in Massachusetts, reported a larger-than-expected increase in its third-quarter net sales on Thursday, but investors pulled back due to ...

Boston Scientific reported third-quarter results that came in ahead of the consensus forecast, raising its 2024 guidance ...

Boston Scientific raised its annual profit forecast and exceeded Wall Street's estimates for third-quarter profit on Wednesday, driven by robust demand for its heart devices, sending its shares higher ...

Canaccord Genuity analyst William Plovanic maintained a Buy rating on Boston Scientific (BSX – Research Report) on October 18 and set a ...